-
-
-
-
-
-
-
Moderna and Merck report sustained melanoma treatment benefits at 5 years
-
-
-
-
-
-
-
Nektar reports mixed phase 2b results for alopecia areata drug
-
-
-
-
-
-
-
Novo Nordisk semaglutide fails to slow Alzheimer's disease in phase 3 trials
-
-
-
-
-
-
-
FDA approves Ironwood's Linzess for pediatric IBS-C patients
-
-
-
-
-
-
-
Trump: No Reason To Give Newborn Babies Hepatitis B Vaccines
-
-
-
-
-
-
-
Aquestive says FDA won't require advisory meeting for Anaphylm drug
-
-
-
-
-
-
-
Axogen receives three-month FDA review extension for Avance Nerve Graft
-
5,908 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Hot FDA News reports.

